Ethics approval and consent to participate:
Animal and Human Rights Statement This study did not involve human experimentation. Biosafety evaluations were approved by the National Institute for Viral Disease Control and Prevention, China CDC. All experimental operations were handled following the Standard Operational Protocol approved by China CDC.
Consent for publication
Written informed consent for specimen collection, testing and publication was obtained from all individuals (or their parents) in the study population.
Availability of data and materials
Condensed anonymized data are available from the corresponding author on reasonable request. Whole genome nucleotide sequences for the strain determined in this study have been deposited in the GenBank nucleotide sequence database under accession numbers MW473684.
The authors declare no competing interests.
Conceptualization, Fenfen Si, Dongmei Yan; formal analysis, Fenfen Si, Dongyan Wang, Tianjiao Ji, Yong Zhang, Shuangli Zhu, Junhan Li, Wenbo Xu, Dongmei Yan; Writing—original draft preparation, Fenfen Si; Writing—review and editing, Dongmei Yan; Project administration,Dongmei Yan; funding acquisition, Dongmei Yan. All authors have read and agreed to the published version of the manuscript.
This study was supported by the National Key Technology R&D Program of China (Project No. 2017ZX10104001). We also acknowledge the funding received from the Key Technologies R&D Program of the National Ministry of Science (Project Nos. 2018ZX10101002-004-006)、Taishan Scholar Program for Young Experts (tsqn202103187)、National key R & D plan (2021YFC0863000) and Municipal Natural Science Foundation of Beijing of China (L192014). The funding body was not involved in the study design, clinical sample collection, data analysis, and interpretation or writing of the manuscript.
We thank the National Institute for Viral Disease Control and Prevention, for the unidentifed isolate from AFP surveillance.